Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Active not recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 179Lung Neoplasms 60Neoplasms 24Neoplasm Metastasis 17Parkinson Disease 4, Autosomal Dominant Lewy Body 13Mesothelioma, Malignant 12Carcinoma 12Colorectal Neoplasms 11Mesothelioma 9Meningeal Carcinomatosis 8Pancreatic Neoplasms 7Brain Neoplasms 7Melanoma 6Adenocarcinoma of Lung 6Neoplasms by Site 5Colonic Neoplasms 5Advanced Solid Tumors 5Uterine Cervical Neoplasms 4Ovarian Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Non-squamous Non-small Cell Lung Cancer 3Neoplasms by Histologic Type 3NSCLC 3Lung Diseases 3Head and Neck Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Bronchogenic 3Adenocarcinoma 3Thoracic Neoplasms 2

Interventions

Pemetrexed 2Carboplatin 2Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Non-Squamous Non-small Cell Lung Cancer × Pemetrexed × 1 year × Clear all
NCT06396065 2026-03-24

Phase III Study of AK112 for NSCLC Patients

Summit Therapeutics

Phase 3 Active not recruiting
420 enrolled
Thoracic

Non-Squamous Non-small Cell Lung Cancer

NCT05184712 2026-03-04

Phase 3 Clinical Study of AK112 for NSCLC Patients

Akeso

Phase 3 Active not recruiting
322 enrolled
Thoracic

Non-Squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡